Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing

TIPRANKS09-25 23:30

Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2670463425?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-25 23:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2670463425","market":"nz","top_or_hot":-1,"title":"Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing","media":"TIPRANKS","content":"<div>\n<p>Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...</p>\n\n<a href=\"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n","source":"tipranks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-25 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral><strong>TIPRANKS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...</p>\n\n<a href=\"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QQQ","symbol_name":"纳指100ETF","start_time":0,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral","article_id":"2670463425","we_media_id":null,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2670463425","pubTimestamp":1790350237,"columns":[],"sourceInfo":{"source_id":"tipranks_highlight","name":"Tipranks"},"weMediaInfo":null,"summary":"Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QQQ":"纳指100ETF","BK4007":"制药","BK4551":"寇图资本持仓","TECS":"Direxion Daily Technology Bear 3X ETF","QQQA":"ProShares Nasdaq-100 Dorsey Wright Momentum ETF","LABU":"三倍做多标普生物-Direxion","JEPQ":"JPMorgan Nasdaq Equity Premium Income ETF","BK4099":"汽车制造商","BK4585":"ETF&股票定投概念","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","QQQE":"Direxion NASDAQ-100 Equal Weighted Index ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","LCID":"Lucid Group Inc","QQQY":"Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF","NDX":"纳斯达克100指数","BK4555":"新能源车","ONEQ":"Fidelity NASDAQ Composite Index ETF","PSQ":"做空纳斯达克100指数ETF-ProShares","QID":"两倍做空纳斯达克指数ETF-ProShares","IND":"Xtrackers Nifty 500 India ETF","QYLG":"Nasdaq 100 Covered Call & Growth ETF","QNTM":"Quantum Biopharma Ltd.","BK4596":"哈里斯概念","QQQJ":"Invesco NASDAQ Next Gen 100 ETF","IYW":"美国科技ETF-iShares","TQQQ":"纳指三倍做多ETF","LCIZ":"Tradr 2X Short LCID Daily ETF","BK4588":"碎股","03086":"华夏纳指","QQQM":"NASDAQ100指数ETF-Invesco","LCDL":"2倍做多LCID ETF-GraniteShares","GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","QDTE":"Roundhill Nasdaq-100 0DTE Covered Call Strategy ETF","TQQY":"GraniteShares YieldBOOST QQQ ETF","NVIW.SI":"NVDA 3xLongSG261006","FTEC":"Fidelity MSCI Information Techno"},"translate_title":"Quantum BioPharma（纳斯达克股票代码：QNTM）获得 FDA 批准将 Lucid-MS 进入 2 期测试","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/54b966d8f745332e6cd70b78eadcf709","symbols_score_info":{"QQQ":0.6,"TQQY":0.6,"LCIZ":0.6,"TQQQ":0.6,"QLD":0.6,"LCID":1.5,"NQmain":0.6,"IYW":0.6,"QID":0.6,"QYLG":0.6,"LCDL":0.6,"FTEC":0.6,"ONEQ":0.6,"QQQY":0.6,"MNQmain":0.6,"JEPQ":0.6,".IXIC":1.5,"TECS":0.6,"03086":0.6,"LABU":1.5,"QQQJ":0.6,"QQQA":0.6,"IND":0.9,"QNTM":1.5,"QQQM":0.6,"GPIQ":0.6,"NDX":0.6,"QQQE":0.6,"SQQQ":0.6,"NVIW.SI":0.6,"QDTE":0.6,"PSQ":0.6},"content_text":"Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2670463425","isCrawlerRequest":true}